
Varda Closes $187 Million Series C Round with Varda Space CEO Will Bruey 7/11/25
Manifest Space with Morgan Brennan
00:00
Revolutionizing Pharmaceuticals in Microgravity
This chapter explores Varda Space's cutting-edge manufacturing techniques in microgravity, fueled by a significant $187 million funding round. It highlights the company's successful missions focused on drug formulations, including their partnerships with major pharmaceutical firms and the establishment of a biologics lab for space experimentation. The discussion emphasizes the transformative potential of microgravity in optimizing drug development and the evolving landscape of commercial space access that enables these advancements.
Transcript
Play full episode